Break out with AstraZeneca and BCD at ITM Revive, April 28

Register for the ITM conference to gain access to a BCD panel on day 2 of the conference.

AstraZeneca Associate Director Kerrie Henshaw-Cox and BCD Travel experts will present at a virtual conference tackling COVID-related business travel issues pulled straight from today’s headlines. The session, “Beyond borders: How international trends impact the UK market,” will take place April 28, on the second day of the Institute of Travel Management’s Revive Conference.

Join the conversation

Revive ITM Conference | April 27-28 (virtual)
Save the date – Beyond borders: How international trends impact the UK market, April 28 at 1 p.m. CEST

Kerrie Henshaw-Cox, Associate Director, AstraZeneca
Kerrie Henshaw-Cox, Associate Director, AstraZeneca

Henshaw-Cox, who was named Travel Buyer of the Year at the 2019 Business Travel Awards, will join Tony McGetrick, vice president, Regional/Traditional Corporate Sales for BCD in the UK, and Mike Eggleton, BCD’s Director Research for the event. In 30 minutes, the panelists will cover:

  • How events in remote locations can have far-reaching global impact
  • A recap of where we are today in the pandemic vs where we started
  • How AstraZeneca is managing travel along with ever-changing global restrictions and what, if any cues, they’re taking from the market
  • The measures needed to restart travel: what business travelers are telling us about their expectations and the role vaccines play in reopening travel

New on

Stay in the know,
even on the go

Never want to miss a thing?

We'll get you the latest news, trends, insights and BCD news right in your inbox.